mshealthcare > Blog > Immunoglobulins

Category: Immunoglobulins

Immunoglobulin Category Description
Immunoglobulins, also known as antibodies, are specialized proteins produced by the immune system to identify, neutralize, and eliminate harmful pathogens such as bacteria, viruses, and other foreign substances. Immunoglobulin therapies are essential biological medicines used to support, replace, or regulate immune system function in patients with immune deficiencies, autoimmune disorders, neurological conditions, and certain infectious diseases.
Immunoglobulin products are derived from carefully screened human plasma and contain concentrated antibodies that help strengthen the body’s natural defense mechanisms. These therapies play a critical role in preventing infections, reducing immune-related complications, and improving patient outcomes across a wide range of medical conditions.
Common Uses of Immunoglobulins
Primary immunodeficiency disorders
Secondary immunodeficiency conditions
Immune thrombocytopenia (ITP)
Guillain-Barré syndrome (GBS)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kawasaki disease
Autoimmune and inflammatory disorders
Infection prevention in high-risk patients
Types of Immunoglobulin Therapy
Intravenous Immunoglobulin (IVIG)
Subcutaneous Immunoglobulin (SCIG)
Intramuscular Immunoglobulin (IMIG)
Hyperimmune globulin preparations
Benefits of Immunoglobulin Therapy
Enhances immune protection
Helps prevent recurrent infections
Regulates abnormal immune responses
Supports treatment of autoimmune disorders
Improves quality of life for immunocompromised patients
Key Features of Immunoglobulin Products
Plasma-derived antibody preparations
High standards of safety and quality control
Suitable for long-term immune support
Administered under medical supervision
Available in various strengths and formulations
Immunoglobulin therapy has become a cornerstone of modern immunology and patient care, offering effective treatment options for individuals with weakened immune systems and complex immune-related conditions. Proper diagnosis, specialist supervision, and regular monitoring are essential to ensure safe and successful treatment outcomes.

Posted on:

WHY DOCTORS PRESCRIBE PANGRAF 0.25 MG CAPSULE??

PANGRAF 0.25 mghttps://oncomshealthcare.com/pangraf-2mg-a-comprehensive-guide-to-tacrolimus-therapy/ is an immunosuppressant medication containing 0.25 mg of tacrolimus. It is prescribed to prevent the body from rejecting a newly transplanted organ , such as a kidney, liver or heart by lowering the activity of immune system . it contains tacrolimus, a potent calcineurin inhibitor and immunosuppressant. It prevents organ transplant rejection by binding to FKBP-12 to block calcineurin phosphatase , which stops T-lymphocyte activation and schedules the immune system attack on a new kidney, liver or heart.

WHAT ARE PANGRAF 0.25 MG CAPSULES?

PANGRAF 0.25 mg capsule contains tacrolimus as its active salt. It belongs to the class of medications known as immunosuppressant’s and more specifically to a subgroup called calcineurin inhibitors.
Key classification:
• Drug class : immunosuppressant
• Subclass: calcineurin inhibitor
• Active ingredient: Tacrolimus (0.25 mg)
• Primary use: prevention of organ transplant rejection
• Role in supporting immune system to protect transplanted organ: PANGRAF 0.25 mg act as a immunosuppressant to prevent the body from rejecting a newly transplanted organ like a kidney, liver or heart. Rather than supporting the immune system to protect a transplant, its role is to suppress and weaken the immune response.

WHAT ARE THE MEDICAL USES OF PANGRAF 0.25 MG CAPSULES?

Medical uses of PANGRAF 0.25 mg capsules are:
A) Kidney transplantation

PANGRAF 0.25 mg capsule contains tacrolimus, an immunosuppressant medication used to foreclose the body from rejecting a newly transplanted kidney. It lowers the immune system activity so it does not attack the new organ.

• Prevention of acute and chronic kidney transplanted rejections

PANGRAF 0.25 mg works by inhibiting calcineurin and suppressing T-lymphocytes activation, helping the consent the new organ. Lower strengths are often used for precise dose adjustments. It targets T and B lymphocytes to stop them from attacking the new kidney. it stops the chemical signals needed for white blood cells to trigger immune rejection.

• Long-term maintenance therapy 
Small dose capsules help fine-tune maintenance therapy , preventing both acute and chronic rejection by suppressing T-lymphocyte activity , but require careful blood-level monitoring to avoid kidney toxicity.

B) LIVER TRANSPLANTATION 

PANGRAF 0.25 MG prevents the body from rejecting a new liver after transplant . it works by lowering the immune system activity so it does not attack the donor organ . it is typically taken exactly as prescribed by a transplant specialist.

• Prevention of liver transplant rejection

PANGRAF capsule contain tacrolimus , a potent immunosuppressant drug. It is used to prevent the body from  by lowering rejecting a new liver transplantation system activity so it does not attack the donor organ. It helps the body to accept the new liver safely. It also suppresses T and B lymphocytes to stop immune response.

• Support for long-term graft survival
PANGRAF 0.25 mg suppresses the T-cell activity to help the body accept a new organ , thereby supporting long-term graft function and patient survival. It suppresses the immune system so it des not attack the donor organ. It also maintain graft survival and acceptance over time.

C) HEART TRANSPLANTATION

PANGRAF 0.25 mg prevents organ rejection by lowering the immune system activity so the body accepts the new heart. It blocks calcineurin to stop T-cell activation. It weakness white blood cells that target the donor heart. It is a core anti –rejection medication used after a heart transplant. It works by claming the immune system so it does not attack the new heart. Doctors regulary test the blood to keep the medicine at a safe, effective level.

• Prevention of heart transplant rejection
PANAGRAF 0.25 mg works by weakening the immune system so it does not attack the new heart, it must be taken strictly under specialist supervision. It stops specific enzyme pathways needed for immune cell activation.

• Used in combination with other immunosuppressant medications
PANGRAF 0.25 mg contains tacrolimus, that is routinely used in combination with other immunosuppressive medication and corticosteroids to prevent rejection of kidney, liver or heart transplant . it works by suppressing T-lymphocyte activation but combining it require careful clinical monitoring.

HOW PANGRAF 0.25 MG WOKS?
PANGRAF 0.25 mg contains tacrolimus, which works as an immunosuppressant . it stops the immune system from attacking a new transplanted organ by blocking white blood cells called T-cells , helping the body accept the new organ. It works in the following ways:
• Mechanism of action of Tacrolimus
Tacrolimus is a potent immunosuppressant drug that blocks T-cell activation. It binds to an intracellular protein called FKBP-12 and this drug –protein complex inhibits calcineurin. By stopping calcineurin, it prevents the production of interleukin -2 which stops T-cells from multiplying and reduces immune cells activity .

• Inhibition of calcineurin activity
PANGRAF 0.25 contains the active ingredient tacrolimus, which inhibits calcineurin by binding to the intracellular protein FKBP-12 . This drug –protein complex blocks calcineurin phosphatase activity, preventing T-lymphocyte activation and cytokine production to suppress the immune response and prevent organ transplant rejection.
• Suppression of T-lymphocytes activation
PANGRAF 0.25 suppresses the T-lymphocytes activity by binding to an intracellular protein and inhibiting the enzyme calcineurin , which blocks the signaling pathways and cytokine production required to activate and multiply T-cells .
• Prevention of immune-mediated rejection of transplanted organs

PANGRAF 0.25 mg is used with other medications to prevent rejection of a kidney, heart or lung transplant. It works by weakning the body’s defense system to help the body accept the new organ as if were their own.

WHAT ARE THE BENEFITS OF PANAGRAF 0.25 MG CAPSULES?
Benefits of PANGRAF 0.25 mg are:
1. Helps prevents organ rejection
PANAGRAF 0.25 mg helps prevent organ rejection by lowering the immune system so the body accepts the new organ . this is a potent medication that requires a valid prescription and must be administered under the constant supervision of a doctor experienced in transplant medicine.

2) supports long –term graft survival
By lowering the immune system, PANAGRAF 0.25 mg prevents the body from attacking a transplanted kidney, liver or heart thereby supporting long-term graft survival and organ function. It done so by blocks the enzyme required to activate T-lymphocytes . it also lowers the body’s defence reactions against foreign tissues and also helps the body accepts and maintain a new organ over a time.

CONCLUSION
Doctors prescribed PANGRAF 0.25 mg capsule to prevent the body from rejecting a newly transplanted organ such as kidney, liver or heart. It works by safetly lowering the immune response so white blood cells do not attack the new tissue.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS PANGRAF 0.25 MG USED FOR?

PANAGRAF 0.25 mg capsule contains tacrolimus , an immunosuppressant medicine. It is used alongside other medications to prevent the body from rejecting a newly transplanted organ such as a kidney, heart or liver. It works by lowering the activity of the immune system so it does not attack the new organ.

QUESTION: HOW DOES TACROLIMUS PREVENT ORGAN REJECTION?
Tarcolimus is a powerful immunosuppressant medication used to prevent the body from rejecting a transplanted organ such as a kidney, liver ,heart or lung. It works by lowering the immune systems activity so white blood cells do not attack the new organ.

QUESTION: CAN PANGRAF 0.25 MG BE TAKEN WITH FOOD?

PANGRAF 0.25 mg should not be taken with food . it is recommended to take it on an empty stomach –at least 1 hour before a meal to ensure maximum and consistent absorption into ones body.

REFRENCES:

1)https://www.1mg.com/drugs/pangraf-0.25-capsule-135736?wpsrc=Google+Organic+Search

2)https://www.practo.com/medicine-info/pangraf-025-mg-capsule-25883

Posted on:

ROMPAG 50 MG TABLET FOR IMMUNE THROMBOCYTOPENIA (ITP) CARE

ROmpag 50mg is a prescription medication containing the active ingredient Eltrombopag. it belongs to a class of drugs called thrombopoietin (TPO) receptor agonists. The tablet works by stimulating the bone marrow to produce more platelets, thereby reducing the risk of bleeding and bruising in patients with specific blood disorders. It is used to increase the platelet in the blood.

WHAT IS ROMPAG 50 MG TABLET 7’S?

ROmpag 50 mg tablets contains the active ingredient Eltrombopag. This prescription medication is classified therapeutically as a hematopoietic growth factor and action-wise as a Thrombopoietin Receptor Against (TPO_RA). It works by stimulating bone marrow cells to produced more platelets, helping to prevent bleeding and bruising.

Key Classification :

  •  Therapeutic class: Hematopoietic Drug/platelet production stimulant.
  • Pharmacological class: Thrombopoietin Receptor Agonist (TPO_RA)
  •  Chemical class: Biphenyl derivative.

WHAT ARE THE MEDICAL USES OF ROMPAG 50 MG TABLETS?

Medical uses of Rompag 50 mg tablets are:

1) Chronic Immune Thrombocytopenia (ITP)

Rompag 50 mg is an oral thrombocytopenia receptor agonist used to treat chronic immune thrombocytopenia (ITP). It stimulate the marrow to produce new platelets, significantly reducing the risk of bleeding and bruising for patients who have not responded to initial therapies.

  • Increasing platelet count

Rompag 50 mg works by stimulating the bone marrow cells to produce and mature more platelets, thereby lowering the risk of bleeding  and  brusing in patients with specific blood disorders. It is used for adults and children whose platelets count remain dangerously low despite previous treatments .

  • Reducing the risk of bleeding

Rompag 50 mg reduces the risk of bleeding by stimulating the bone marrow to produce more platelets. Because platelets are the blood cells responsible for clotting, raising their levels minimizes spontaneous bleeding, bruising, and severe hemorrhage in patients with low counts.

2) Severe Aplastic Anemia

Rompag 50 mg is an oral thrombopoietin (TPO) receptor against. In severe Aplastic anemia (SAA) ,it helps stimulate the bone marrow to produce new blood cells ,often pushing counts to safe levels and reducing the need for blood and platelet transfusion . unlike standard drugs that simply mask symptoms , Rompag acts directly on hematopoietic stem cells.

3) Thrombocytopenia associated with chronic Liver Disease

Rompag 50 mg contains eltrombopag , an oral thrombopoietin (TPO) receptor agonist. In chronic liver disease , it acts by stimulating the bone marrow to produce platelets, offsetting the reduced TPO production caused by liver dysfunction .

  • Managing low platelet levels before medical procedures

Before a medical or surgical procedures , the primary role of Rompag 50 mg is to stimulate the bone marrow to rapidly produce platelets, elevating the platelet count to a safe level to significantly reduce the risk of excessive bleeding. It mimics the natural hormone thrombopoietin ,binding to receptors on bone marrow cells to trigger their growth , multiplication, and maturation into functioning platelets.

  • Reducing procedure –related bleeding risk

Reducing procedure related bleeding risk in thrombocytopenia involves strategic management of platelet counts and the specific procedures.

Key approaches include :

a) Pre-procedure platelet transfusions

b) Medical Bridging therapies

c) Antifibrinolytic Agents

d) Local hemostatic measures

e) Medication review

HOW  ROMPAG 50 MG WORKS?

Rompag 50mg is a thrombopoietin (TPO) receptor agonist. It works by mimicking the natural thrombopoitein to stimulate bone marrow cells called megakaryocytes. This stimulation causes the bone marrow to produce and mature new blood platelets, helping to clot blood and prevent bleeding ad bruising.

Rompag 50 mg works in the following ways:

• Mechanism of action of Eltrombopag

Rompag is a thrombopoitein receptor agonist. Its primary mechanism of action is to bind to and stimulate the TPO receptor in the bone marrow , signaling the body to produce and mature more platelets (thrombocytes) . unlike natural thrombopoietin , Electrombopag binds to the transmembrane domain of the TPO receptor. It completes rather than competes with natural TPO.

• Stimulation of thrombopoitein receptors

Rompag 50 mg is an oral thrombopoietin (TPO) receptor against used to treat low platelet counts. It boosts platelet production in conditions like immune Thrombocytopenia (ITP) and severe aplastic anemia. Unlike the body’s natural thrombopoietin, which binds to the outside of the TPO receptor, Eltrombopag binds directly to the receptors trans-membrane domain. This binding stimulates intracellular signaling via the JAK/STAT pathway, which stimulate the bone marrow to increase the proliferation and differentiation of homoeopathic stem cells and megakaryocyte progenitors.

• Promotion of platelet production in the bone marrow

Rompag 50 mg is an oral thrombopoietin (TPO) receptor against. It promotes platelet production in the bone marrow by mimicking natural TPO, binding to bone marrow stem cells ,and triggering the JAK/STAT signaling pathway. These activated pathways stimulate the proliferation and differentiation of megakaryocytes, which are the specialized ,giant cells in the bone marrow responsible for making platelets. Once fully mature, these megakaryocytes shed and release platelets into the bloodstream.

• Maintenance of healthy platelet levels

For patients relying on Rompag, maintenance requires careful management . calcium significantly interferes with how ones body absorb the drug. One must avoid taking Rompag within 2 hours before or 4 hours after consuming calcium –rich foods or drinks. It is generally taken once a day ,the doctor will adjust the dosage based on routine blood test and ones bleeding risk.

WHAT ARE THE BENEFITS OF ROMPAG 50 MG TABLETS?

Benefits of Rompag 50 mg tablets are:

1) Helps increase platelets counts

Yes, Rompag 50 mg is prescribed specifically to help increase platelet counts. It belongs to the class of medications called thrombopoietin receptor agonist . it mimics the natural hormone thrombopoetin , signaling the bone marrow to produce more megakaryocytes. By increasing the platelet count, it helps prevent and minimize excessive bleeding or bruising.

2) Reduces bleeding complications

Rompag 50mg works by stimulating the bone marrow to produce more platelets, which help prevent and reduce bleeding complications in patients with low platelet count. It must be taken on an empty stomach , at least 2 hours before or 4 hours after consuming dairy products , antacids or mineral supplements .

3) Support management of chronic blood disorders

Rompag 50 mg is a prescription medication used to manage chronic blood disorders by stimulating the bone marrow to produce more platelets. It decreases the risk of bleeding .it act as a thrombopoietin (TPO) receptor against ,mimicking natural hormones to signal the body to generate new platelets .

CONCLUSION

Roompag 50 mg is a medication that boost platelet counts to treat conditions like immune thrombocytopenia (ITP), severe Aplastic Anemia and HCV- associated low platelets . it works by stimulating bone marrow to produce new cells. It is an effective, life-saving medication for raising dangerously low platelet count. However, it is a potent prescription drug that requires strict medical supervision and regular blood test to prevent blood clots or liver strain.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS ROMPAG 50 MG TABLET USED FOR?

 Rompag 50mg is a prescription medication used to treat low blood platelet counts in patients who are at risk of bleeding. It stimulate the bone marrow to produce more platelets.

QUESTION: HOW LONG DOES IT TAKE TO INCREASE PLATELET COUNTS?

Rompag 50 mg typically takes about 1 to 2 weeks to being increasing ones platelet count. It works by stimulating the bone marrow to produce more platelets, with counts often peaking roughly 10 to 14 days after starting treatment .

QUESTION: WHY ARE REGULAR BLOOD TEST NECCESARY DURING TREATMENT ?

Regular blood test are critical during Rompag 50mg treatment to ensure ones platelet counts stay within a safe range to monitor for potential organ damage.

REFRENCES:

1)https://www.1mg.com/drugs/rompag-50mg-tablet-942791?srsltid=AfmBOoqTkBeDGw4YvCaK7Vb0YcXHJss-5PWAY0UHUKm7YBEjd9batuVW&wpsrc=Google+Organic+Search

2)https://m.indiamart.com/proddetail/rompag-50-mg-tablets-2851526276091.html

Posted on:

HOW ELROMO 50 MG SUPPORT PATEINT TREATMENT AND CARE?

 

 

Elromo 50 mg is a prescription oral medication primarily used to treat low blood platelets count in conditions like chronic immune thrombocytopenia (ITP) and severe aplastic anemia. It stimulates the bone marrow to produce more platelets ,reducing bleeding and bruising. It plays a crucial role in managing low platelet count by reducing bleeding risk and supporting continuous medical treatments like chemotherapy.

WHAT IS ELROMO 50 MG?

Elromo 50 mg is classified as a thrombopoietin (TPO) receptor agonist. It function as a hematopoietic growth factor that stimulate the bone marrow to produce more platelets, reducing risk of bleeding.

Key classification:

• Active ingredient : Eltrombopag 50 mg.

• Role in hematology treatment: used to increase platelets counts and prevent bleeding in patients who have not responded to corticosteroids ,immunoglobins or spleen removal surgery.

 

WHAT ARE THE MEDICAL USES OF ELROMO 50 MG?

Medical uses of Elromo 50 mg are:

1) TREATMENT OF LOW PLATELET DISORDER

• Chronic immune thrombocytopenia (ITP)

Elromo 50 mg is a standard oral medication used to manage chronic immune thrombocytopenia (ITP) by stimulating the bone marrow to produce platelets. It is typically prescribed for adults and children whose platlets count remain low after prior treatments like corticosteroids ,immunoglobulins or splenectomy.

 

• Severe Aplastic anemia

In severe Aplastic anemia, it is used to promote multi-lineage blood cell recovery, reduce dependency on transfusions and improve overall response rates.

• Thrombocytopenia associated with chronic liver disease

Elromo 50 mg is an oral thromobopoitein (TPO) receptor agent. Its primary role is to stimulate the bone marrow to produce platelets, thereby safely raising platelet counts in pateints with chronic liver disease (CLD) and severe thrombocytopenia prior to scheduled invasive medical or surgical procedures. It is specifically prescribed to reduced or completely avoid the need for prophylactic platelet transfusions before planned invasive procedures.

2) HEAMATOLOGICAL SUPPORT

  • Increasing platelet production

Elromo 50mg is an oral medication designed to increase platelet production in the body. It is commonly prescribed to treat low platelet counts in conditions such as chronic immune thrombocytopenia and severe aplastic anemia. By boosting the number of precursor cells, it rapidly increases the overall production and release of new platelets into the bloodstream.

• Reducing bleeding risks

Elromo 50 mg reduces bleeding risk by stimulating the bone marrow to produce more platelets. It is a thrombopoietin receptor prescribed for adults with chronic immune thrombocytopenia (ITP) , severe aplastic anemia, or low platelets due to hepatitis c. elevating the platelet count helps the blood clot more effectively , minimizing spontaneous bruising and severe bleeding.

 

• Supporting long-term disease management

Elromo 50mg supports long-term disease management for patients with chronic immune thrombocytopenia (ITP) , severe aplastic anemia, and low platelets associated with hepatitis C. for patients with hepatitis C ,it ensures safe platelet levels so they can start or continue interferon-based antiviral therapies.

HOW ELROMO 50 MG WORKS?

Elromo 50 mg is a targeted medication used to treat low blood platelet counts in conditions like immune thrombocytopenia , severe aplastic anemia, and Hepatitis C

. it works by the following ways:

• Stimulating thrombopoietin receptors

Elromo 50 mg is a targeted thrombopoietin (TPC) receptor against. It stimulates platelets production by binding directly to the transmembrane domain of the TPO receptor promoting cellular signaling cascades that drive cell proliferation ,differentiation and an increase in mature platelets.

• Promoting platelet production in the bone marrow

Elromo 50 mg work as a thrombopoietin (TPO) receptor agonist. This medication is typically prescribed to treat low platelet counts in conditions like chronic immune thrombocytopenia, severe aplastic anemia, and hepatitis c –related thrombocytopenia.

 

• Helping maintain healthy platelet level

Elromo 50 mg helps maintain healthy platelet levels by acting as a TPO receptor against. This boost the platelet count ,lowering the risk of spontaneous bleeding and bruising. By restoring platelet counts to safer levels, it minimize the risk of hemorrhage ,brushing and severe nosebleeds or gum bleeding.

WHAT ARE THE BENEFITS OF ELROMO 50 MG?

Benefits of Elromo 50 mg are:

1. Reduce risk of bleeding complications

Elromo reduces bleeding risk by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. It is typically prescribed for chronic immune thrombocytes (ITP), severe aplastic anemia, caused by hepatitis C. To effectively reduce the risk of bleeding, ensure the medication works safely, it is critical to manage how it is taken and monitor for side effects.

2. Supports treatment of chronic blood disorders

Elromo 50 mg supports the treatment of chronic blood disorders by stimulating the bone marrow to produce more platelets and blood cells. It act as a thrombopoietin(TPO) receptors to prevent spontaneous bleeding and bruising.

3. Improves patient quality of life

Elromo 50 mg significantly improves patient quality of life by stimulating the bone marrow to increase platelet production, reducing the anxiety , fatigue, and physical limitations associated with spontaneous bruising, bleeding and severe thrombocytopenia

. it improves quality of life by the following ways:

A) Reduces bleeding risk: by elevating platelet counts to safer threshold, the medication prevents life-altering or fatal spontaneous internal and external bleeding episodes.

B) Oral convenience : as a daily tablet, it eliminates the need for frequent , painful injections in clinical settings, granting pateints greater autonomy and mobility.

WHO SHOULD AVOID ELROMO 50 MG?

Elromo 50 mg should be avoided by:

1) Patients allergic to Eltrombopag

2) Individuals with severe liver complications

3) Patient at a high risk of blood clots

4) Cases requiring special dose adjustment

 

CONCLUSION

Elromo 50 mg is a prescription medication utilized to treat low blood platelets count in individuals with chronic immune thrombocytopenia (ITP) ,severe aplastic anemia, and chronic hepatitis C. it function as a thrombopoietin (TPO) receptor against, which stimulates the bone marrow to produce more platelets and lower the risk of bleeding episodes.

 

FREQUENTLY ASKED QUESTIONS (FAQs):

 

QUESTION: WHAT IS ELROMO 50 MG USED FOR?

 

Eloromo 50 mg is used to treat low blood platelets count in specific conditions where other treatments have been ineffective . it is used to stimulate platelet production in adults and children whose bodies destroy their own platelets ,putting them at high risk of bleeding and brusing.

 

QUESTION: HOW LONG DOES IT TAKE TO INCREASE PLATELET COUNTS?

For most patients, taking a 50 mg dose of elromo ,platelets counts typically begins to increase within 1 to 2 weeks, with peak responses often observed after 2 to 4 weeks of therapy.

 

QUESTION: CAN IT BE TAKEN WITH CALCIUM-RICH FOODS?

No one should not take elromo 50 mg with calcium-rich foods. Calcium binds to the medication, preventing the body from absorbing it properly and making it ineffective.

REFRENCES:

1)https://www.apollopharmacy.in/medicine/elromo-50-tablet-7-s?srsltid=AfmBOooS_xLB2j1-8XoiRszJlmAGiHmhVj4ZG2fRb-JUG_7gtPoVo01Q

2)https://oncohealthmart.com/product-details/1591/elromo-50mg-tablet/ Read more “HOW ELROMO 50 MG SUPPORT PATEINT TREATMENT AND CARE?”

Add to cart